FDA webpage giving IDE overview
CDRH Learn module “Clinical Studies/Investigational Device Exemption (IDE)” IDE Basics from 11/4/2014
CDRH Learn module “Clinical Studies/Investigational Device Exemption (IDE)” Early Feasibility Study (EFS) Program
CDRH Learn module “Clinical Studies/Investigational Device Exemption (IDE)” Breakthrough Devices Program from 01/17/2019
FDA webpage with list of guidances related to IDEs
FDA Decisions for Investigational Device Exemption Clinical Investigations Guidance for Sponsors, Clinical Investigators, Institutional Review Boards, and Food and Drug Administration Staff – August 2014
Information Sheet Guidance For IRBs, Clinical Investigators, and Sponsors Significant Risk and Nonsignificant Risk Medical Device Studies – January 2006
Back to Top
CDRH Learn module “De Novo” De Novo Classification Process (Evaluation of Automatic Class III Designation) from 11/21/2017
Taped presentation from REdI Spring 2018 Conference (May 15, 2018 Device Track) “De Novo Classification Requests”
FDA De Novo database
De Novo Classification Process (Evaluation of Automatic Class III Designation) Guidance for Industry and Food and Drug Administration Staff – October 2017
FDA webpage giving 510(k) overview
CDRH Learn module on “Premarket Notification (510k)” The 510(k) Program from 11/4/2014
CDRH Learn module on “Premarket Notification (510k)” Benefit-Risk Factors to Consider When Determining Substantial Equivalence in Premarket Notifications [510(k)] with Different Technological Characteristics from 11/1/2018
FDA webpage on preparing a traditional 510(k)
FDA webpage on preparing an abbreviated 510(k)
FDA 510(k) database
The 510(k) Program: Evaluating Substantial Equivalence in Premarket Notifications [510(k)] Guidance for Industry and Food and Drug Administration Staff – July 2014
Safety and Performance Based Pathway Guidance for Industry and Food and Drug Administration – February 2019
FDA webpage giving PMA overview
Taped presentation from REdI Spring Conference (May 9, 2017 Device Track) “Introduction to the Premarket , Approval (PMA) Program”
FDA PMA database
FDA webpage with list of guidances related to PMAs
Acceptance and Filing Reviews for Premarket Approval Applications (PMAs) Guidance for Industry and Food and Drug Administration Staff from 02/2019
CDRH Learn module “Humanitarian Use Device (HUD)/Humanitarian Device Exemption (HDE)” Humanitarian Use Device (HUD): Program Overview
CDRH Learn module “Humanitarian Use Device (HUD)/Humanitarian Device Exemption (HDE)” Humanitarian Device Exemption (HDE): Program Overview and Pre-approval Activities
FDA HDE database
Guidance for Industry and Food and Drug Administration Staff Humanitarian Use Device (HUD) Designation– January 2013